Julie Diana Smith

All filings by Julie Diana Smith on record concern Meridian Bioscience Inc. In total, 5 filings cover trades dated from 16 September 2022 to 31 January 2023.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 31 January 2023 came the latest disclosure, a share grant in Meridian Bioscience Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.